You are here

United States

WHO elevates XBB.1.16 to variant of interest as levels rise in US and other countries

The World Health Organization (WHO) this week boosted the XBB.1.16 Omicron subvariant to a variant of interest (VOI) from a variant under monitoring (VUM), based on the latest assessments from its technical advisory group on virus evolution.

The subvariant is fueling India's biggest surge in about 7 months, and the US Centers for Disease Control and Prevention (CDC) reported another jump in the proportion of XBB.1.16 viruses.

Problem, Solution, SitRep, or ?: 

Analysis: House Republicans Eye Rescinding Unspent Covid Money but it would not make much dent in the national debt

WASHINGTON — House Republicans demanding spending cuts in exchange for raising the nation’s debt limit have rallied around a seemingly straightforward proposal: recalling billions of dollars in coronavirus relief funds that Congress approved but have not been spent.

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

U.S. charges 18, including doctors, with COVID-19 fraud schemes

...

Justice Department officials said the law enforcement action was the largest ever to target healthcare schemes that exploited the pandemic, resulting in charges laid against 18 defendants in nine federal districts and more than $16 million in cash seized.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Opinion: The NIH has little to show for the $1 billion spent to study long Covid

...

The National Institutes of Health hasn’t signed up a single patient to test any potential treatments — despite a clear mandate from Congress to study them. And the few trials it is planning have already drawn a firestorm of criticism, especially one intervention that experts and advocates say may actually make some patients’ long Covid symptoms worse.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Two drug combination shows protection against severe COVID-19

Two new randomized, controlled trials published yesterday in the Annals of Internal Medicine describe how drug combinations lowered the risk of severe COVID-19, with one detailing use of the antidepressant fluvoxamine plus the corticosteroid budesonide, and the other outlining the monoclonal antibody duo amubarvimab plus romlusevimab.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to United States
howdy folks